Next Article in Journal
Saprophytic Filamentous Fungi against Helminths Affecting Captive Wild Animals
Previous Article in Journal
Public School Choice Options in the United States
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Entry

Bacteriocins and Bacteriophages as Dual Biological Players for Food Safety Applications

1
Laboratoire de Microbiologie Appliquée, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia 06000, Algeria
2
UMR Transfrontalière BioEcoAgro INRAE 1158, Univ. Lille, Univ. Liège, UPJV, YNCREA, Univ. Artois, Univ. Littoral Côte d’Opale, ICV–Institut Charles Viollette, F-59000 Lille, France
3
Instituto de Productos Lácteos de Asturias, CSIC, Paseo Rio Linares s/n., 33300 Villaviciosa, Spain
4
Biology Program and Honors College, Oregon State University–Cascades, 1500 SW Chandler Avenue, Bend, OR 97702, USA
*
Author to whom correspondence should be addressed.
Encyclopedia 2024, 4(1), 79-90; https://doi.org/10.3390/encyclopedia4010007
Submission received: 22 September 2023 / Revised: 19 December 2023 / Accepted: 30 December 2023 / Published: 2 January 2024
(This article belongs to the Section Biology & Life Sciences)

Definition

:
The development of new techniques for the control of pathogenic microorganisms during food production and for the prevention of spoilage are needed to reduce or replace chemical preservatives. This is due to the trend that consumers are increasingly questioning the use of chemical preservatives because of the many health concerns. Because of this issue, bacteriocins and bacteriophages are increasingly viewed as safe natural preservatives with a long history of various applications during food production and preservation. This minireview considers applications of these two antimicrobials, highlights their mode of action, lists their advantages and, when necessary, their limitations. It also reports recent advances in the use of bacteriophages and bacteriocins either alone or in combination in different food matrices. The incentives and effectiveness offered by these antimicrobials in the field of biopreservation are considered for future applications during food production and preservation.

1. Introduction

Foodborne pathogens are responsible for many diseases worldwide. Their presence and persistence in the production environment of the food industry are most often associated with inappropriate disinfection procedures or failure to follow hygiene regulations, making them potentially problematic in this sector [1]. Despite the effectiveness of chemical and physical cleaning techniques, bacteria can evade adverse conditions and persist due to their ability to organize themselves into a multispecies biofilm. This structure is mainly composed of bacterial polymeric extracellular matrix, exopolysaccharides (EPS) and DNA, which enables multispecies bacterial biofilms to withstand harsh conditions. In addition, physical and chemical treatments are not always effective in eliminating biofilms, resulting in potential contamination and alteration of food products, compromising food health and safety [2].
There is growing consumer concern about the adverse effects of treating food with potentially harmful chemicals. This ever-increasing trend has led to a heightened awareness of foods prepared and served with natural ingredients [3]. In this light, bacteriophages, which are bacteria-infecting viruses, and bacteriocins, which are ribosomally produced antimicrobial peptides, could serve as a means to reduce foodborne and spoilage bacteria, as a potential alternative to chemical additives [4,5]. This brief review describes what bacteriocins and phages are and then focuses on their potential applications in the food production and preservation sector.

2. Bacteriocins

Briefly, bacteriocins are synthesized by both Gram-positive and Gram-negative bacteria as well as members of the Archaea [6]. In the group of Gram-positive bacteria, the most well-studied bacteriocins are produced by lactic acid bacteria (LAB), with Generally Recognized As Safe (GRAS) status. The first model of a protease-sensitive LAB-bacteriocin was attributed to Lactococcus lactis formerly described as Streptococcus lactis [7]. These bacteriocins are extracellular antimicrobial peptides ribosomally synthesized, released in their synthesized state or after post-translational modification, which may have a phylogenetically narrow spectrum of bactericidal activity and against which this bacterium possesses a number of specific protective mechanisms [8]. In addition to producing lactic acid as the main end product of sugar fermentation, LAB produces different bacteriocins. These antimicrobial peptides display different characteristics in terms of molecular weight, biochemical properties, spectrum of activity and mode of action [9]. The LAB-bacteriocins were also reported to be noncytotoxic, pH stable and do not affect the gut microbiota because of their sensitivity to the host digestive proteases [10]. LAB-bacteriocins were first categorized by Klaenhammer [11] and then, in different successive classifications, such as those proposed by other investigators [9,12,13,14,15]. Recently, a simplified classification has been suggested by Soltani et al. [16] that includes bacteriocins from both Gram-negative bacteria and Gram-positive bacteria in two main categories. These are class I (modified bacteriocins) and class II (unmodified). Briefly, class I contains small, low molecular weight peptides < 5 kDa, that undergo post-transcriptional modifications, whereas class II bacteriocins comprise unmodified peptides with molecular weights ranging from 6 to 10 kDa. Of note, class I is divided into several subclasses, including lanthipeptides, sactipeptides, circular peptides and lasso peptides from Gram-positive and Gram-negative bacteria. Class II bacteriocins include pediocin-like bacteriocins with a YGNGV consensus sequence and unmodified non pediocin-like bacteriocins [16].
In recent years, LAB-bacteriocins have become of increased interest because of their GRAS status [17] and because of their use as biopreservative agents of choice in the food industry to replace chemical agents [18]. Except in some cases of Gram-negative bacteria inhibition [19,20,21,22,23], LAB-bacteriocins are most often active against Gram-positive target strains, which are phylogenetically related to the producing strains [8]. In fact, the absence of activity across Gram-negative bacteria could be explained by the outer membrane, which impedes their access to the inner membrane, where they exert their activity [24]. This argument is no longer valid as some LAB-bacteriocins, as referenced previously, display inhibitory activities towards Gram-negative bacteria through mechanisms that remain to be elucidated [25].

3. Bacteriocins in the Food Industry

According to Lahiri et al. [26] bacteriocins should fulfill several criteria, and as such, have to (i) be safe for the human consumption and not negatively impact human gut microbiota, (ii) possess a broad spectrum of antimicrobial activity against foodborne pathogens, (iii) include industrial features like resistance to enzymes in the food matrix, (iv) have stability at elevated temperatures in a wide range of pH values and (v) various salt concentrations [26]. Despite the number of reports on bacteriocins’ ability to be introduced in the food sector as biopreservative agents, only nisin and, to a lesser extent, pediocin PA-1/AcH have been authorized as commercial biopreservative agents. Of note, sakacin, plantaricin and carnosine have been proposed as new bioprotective bacteriocins and their development was undertaken to disrupt biofilms [27].
The use of bacteriocins in the food industry is relevant, given their capability to inhibit a wide range of foodborne pathogens and spoilage microorganisms [28]. Because of this attribute, the use of LAB or their metabolites has become increasingly common [29]. Besides their inhibitory properties, which help to expand the food products shelf life, bacteriocins present added properties, such as their inability to positively affect the organoleptic and nutritional value of these food products [30,31,32,33]. Therefore, applications of LAB-bacteriocins can significantly reduce the use of chemicals and respond to the consumer expectations, who are steadily disclaiming the use of chemical food preservatives. LAB-bacteriocins can have a broad or narrow spectrum of activity, enabling them in certain cases to specifically target harmful bacteria, such as Listeria monocytogenes [33]. Of note, biofilm formation is a major concern in the food industry, and both pathogenic and spoilage microorganisms can adopt this mode of life, which can compromise disinfection procedures. This contributes to their persistence in the environment and presence on equipment used in the food processing facilities, leading to recurrent cross-contamination of various food products [34]. This results in a threat to the global hygienic value of many food products. LAB-bacteriocins display a potential to disrupt biofilm formation by undesirable pathogenic or spoilage bacteria, such as Salmonella, Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, L. monocytogenes and Bacillus cereus [27,35,36]. The adsorption of bacteriocins could be used as a preventive biological means to interfere with bacterial adhesion on abiotic supports and subsequently disrupt biofilm formation. Consequently, bacteriocins associated with other substances offer further advantages and could be the next approach in the agri-food industry to prevent biofilm formation [36].
Bacteriocins in the food industry can be applied in various systems. In fact, bacteriocinogenic strains (bacteriocin producers) could be applied directly in foods, allowing for in situ production and effectiveness in reducing foodborne pathogens, such as L. monocytogenes. This approach has been proven during different investigations [37,38]. Furthermore, processes also consist of using purified or semi-purified bacteriocins. Perhaps as a more cost-effective process, bacteriocins can be simply applied as a concentrate resulting from the fermentation of a food substrate, and finally, they may be encapsulated, which enhances their stability and efficacy during processing and preservation [22,39,40,41,42]. Bacteriocins can also be used in “smart” packaging to control foodborne pathogens and increase the shelf life of a food product [43,44].
Bacteriocins are clearly suitable for food applications. These small antimicrobial peptides (AMPs) are naturally produced by a number of LAB from fermented foods [45,46]. Related to that, multiple assays of bacteriocin applications have been reported in the literature and presented in Table 1, proving the effectiveness of these natural molecules as effective alternatives to chemically conserved food products.
Importantly, to prevent bacterial resistance to bacteriocins, it should be noted that combinations of bacteriocins with other antimicrobials could lead to synergistic interactions and reduce the phenomenon of resistance. In this light, bacteriocins have been successfully tested with chemical preservatives [31], inulin [47], natural phenolic compounds and essential oils [48,49]. Because of their distinct mode of action, these combinations, as above stated, reduce or prevent the development of resistant bacterial strains. Moreover, bacteriocins have been reported to support various applications when tested collectively with physical treatments [41], such as high pressure [50] or pulsed electric fields [51]. Finally, the combination of bacteriocins with bacteriophages to combat foodborne pathogens continues to result in the design of promising prospective interventions to reduce foodborne bacterial disease and inhibit food spoilage [4,52,53].
In summary, the use of bacteriocins in the food sector offers a number of useful advantages. These antibacterial products are nontoxic and easily metabolized by digestive enzymes [16,33]. Their global use will represent a breakthrough in the food sector, as they are expected to reduce both the use of chemical products and the intensity of the current heat treatment procedures [27,33]. This approach will also be very useful in creating environmentally and economically friendly products that meet consumer expectations.
Table 1. Examples of bacteriocins and their targets to be used as biopreservative agents in the food sector.
Table 1. Examples of bacteriocins and their targets to be used as biopreservative agents in the food sector.
Producing StrainBacteriocinApplicationTarget MicroorganismReference
Pediocooccus acidilactici PAC1.0Pediocin PA-1/AcHRaw chickenListeria monocytogenes[54]
Latilactobacillus sakei Lb674Sakacin PChickenListeria monocytogenes[55]
Enterococcus faecium
CTC492
Enterocins A and BHamListeria monocytogenes,
Lactobacillus sakei
[56]
Enterococcus faecium L50Enterocin L50A/L50BBeersLactobacillus brevis,
Pediococcus damnosus
[57]
Enterococcus faecium FL31Bacteriocin BacFL31Ground turkey meetListeria monocytogenes
Salmonella Typhimurium
[58]
Lactococcus lactis CSK3533
Lactiplantibacillus plantarum LMG P-26358
Nisin/Lacticin 3147/PlantaricinCheeseListeria monocytogenes[59]
Lacticaseibacillus rhamnosus RC20975Bacteriocin RC20975Apple juiceAlicyclobacillus acidoterrestris[60]
Lactiplantibacillus plantarum BM-1Plantaricin BM-1Fresh pork meatListeria monocytogenes[61]
Lactobacillus crustorum MN047Bacteriocin BM1300Beef meatStaphylococcus aureus
Escherichia coli
[62]
Lactiplantibacillus plantarum S7-10Plantaricin E and FHoneybeePaenibacillus larvae[63]
Lactococcus lactis CAU2013 Fresh cheeseListeria monocytogenes[38]
Lactococcus lactis F01bacteriocin peptide C4BFish sausageClostridium sp., Staphylococcus aureus, Bacillus subtilis, Salmonella Typhimurium, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli[64]
Lactiplantibacillus plantarum Table grapesPseudomonas syringae pv. syringae and Botrytis cinerea[65]
Limosilactobacillus panis C-M2Lactocin C-M2Fish Staphylococcus aureus[66]
Enterococcus faecalis L2B21K3 and L3A21K6 Ripened cheeseListeria monocytogenes[67]

4. Bacteriophages

Historically, bacteriophages were discovered at the beginning of the 20th century by Frederick Twort and Félix d’Herelle, and they were proposed for use as antibacterial agents [68]. The discovery and development of antibiotics (ATBs) in the following decades was the main reason for the decline in the use of bacteriophages to treat bacterial infections in Western countries [69]. In addition, there have been failures and certain factors that have exacerbated the significant decline in bacteriophage research, including (i) the lack of understanding of the heterogeneity and ecology of phages and bacteria; (ii) the risk of selecting highly virulent phages against the patient’s target bacteria; (iii) the use of single phage preparations to treat infections involving mixtures of different bacteria; (iv) the emergence of bacterial host mutants that may be resistant to bacteriophages; and (v) the lack of appropriate characterization or titration of phage preparations; (vi) the lack of gastric pH neutralization prior to oral administration; (vii) the inactivation of phages by the host immune response; (viii) the presence of endotoxins in the phage preparation, and (ix) the lack of a reliability interlaboratory identification of the pathogens responsible for infections [70]. The phenomenon of resistance to ATBs and their global spread is now generating renewed interest in the search for innovative strategies to alleviate this problem. More attention is now being paid to bacteriophages for clinical applications in human and veterinary medicine and in food production [71,72,73].
Phages are ubiquitous and play an important role in a wide range of biological processes. They are considered to be the most abundant microorganisms on the planet, with an estimated number of 1031 in the biosphere [74]. The vast majority of known phages are tailed bacteriophages with double-stranded DNA [75,76]. Unlike traditional ATBs, bacteriophages are highly species-specific, which allows them to potentially maintain an intact microbiota and be adapted for use in food products where they do not alter organoleptic properties or the texture of foods [72,77]. Further advantages attributed to bacteriophages include (i) the low likelihood of inducing comparative antibiotic resistance; and (ii) the potent antibiofilm activity of bacteriophages [78].
The interaction between a bacteriophage and the bacterial host drives the bactericidal activity of bacteriophages. This results in the development of a lytic cycle during which the bacteriophage phage genome replicates, followed by transcription and translation, resulting in capsid formation. After assembly, the host cell is lysed by the lytic enzymes called endolysins, in combination with the holins encoded by the phage genome, and the newly formed bacteriophages are released into the environment [79]. Globally, the lytic cycle of bacteriophages consists of an adsorption step (Figure 1), resulting in an irreversible adhesion to the bacterial cell surface involving interactions between the phage attachment proteins and their specific bacterial cell-surface receptors. The receptors are found in the outer membrane, such as LPS for Gram-negative bacteria or teichoic acid and lipoteichoic acid for Gram-positive bacteria on the bacterial cell wall. Efficient recognition of specific phage receptors leads to attachment of the virus and injection of genetic material into the host cell. This process is strictly dependent on the environment and its physico-chemical factors, pH, temperature, availability of nutrients or ions, and physiological state of the bacterial cell [80,81].

5. Bacteriophages in the Food Sector

Bacteriophages are a major cause of milk fermentation failure due to their infection of bacterial starter cultures [82]. However, their use alone or in combination with other antibacterial agents is a promising means to be utilized in the food sector to fight pathogenic and spoilage bacteria [71]. As reported, phages are abundant in the environment. Their presence has been pointed out in unpolluted water at levels of 2 × 108 bacteriophages/mL, and they are regularly consumed in foods [69].
Importantly, phages predicted for use as antimicrobials should possess several important characteristics [71]. For example, they should undergo lytic cycles and not lysogenize as prophages. Their host range must cover all epidemiologically relevant strains found in the targeted species. In addition, phages with minimal transduction capacity should be used to avoid phages that could transmit bacterial DNA to subsequent hosts. Next, their stability in the environment of use should be considered important for food applications. There is also the possibility of developing resistance to these biological agents, but this limitation could be mitigated by using phage cocktails rather than a monophagic preparation [71,83]. The Food and Drug Administration (FDA) approved the ListShield™ phage consortium against L. monocytogenes as a food additive in 2006. Subsequently, the number of bacteriophage preparations for human consumption that have received GRAS status from the FDA has expanded to include SalmoFresh™ and PhageGuard S™ [84]. The efficacy of new phage preparations has been confirmed by numerous studies that have demonstrated their effectiveness against the most commonly implicated foodborne bacterial pathogens [85]. It should be noted that bacteriophages are also used in animals and in the production of meat such as poultry and fish [70,79], as well as in the development of smart food packaging [86]. Bacteriophages have been successfully used in the treatment and diagnosis of plant diseases and in the biocontrol of phytopathogenic bacteria [87,88]. Phages have also been used in wastewater treatment [89] and are widely used for pathogen control and detection in the dairy industry [90,91,92].
The lytic effect of phages against L. monocytogenes has been reported in several studies [78,91,93,94,95,96] as this bacterium is the etiology of listeriosis disease in humans. Phages have a high lethality rate against their bacterial hosts and can be found at any point in the food production process, even during storage, due to the ability of phages to persist at temperatures < 0 °C [97]. In this regard, the consortium of LM-103 and LMP-102 phages was found to reduce the load of L. monocytogenes, including the serotypes 1/2a, 1/2b and 4b commonly associated with human listeriosis, by 2.0 to 4.6 log units compared to the control on honeydew melons [52]. It is also important to eliminate or reduce the persistence of L. monocytogenes in the form of biofilms on various surfaces in the agri-food industry. In this context, bacteriophage P100 solution, when applied at 8 log PFU (plaque forming units)/mL, successfully removed L. monocytogenes serotype 1/2a (LM6) biofilms from polystyrene surfaces [98]. Another targeted foodborne bacterial pathogen is Staphylococcus aureus, which produces heat-stable enterotoxins, adopts to a biofilm lifestyle, can develop antibiotic resistance and can evolve genetic mutations that lead to harmful strains, such as those derived from methicillin-resistant S. aureus (MRSA) [99]. In a recent study conducted by Kwak et al. [100], it was reported that the application of bacteriophage KMSP1 at a multiplicity of infection (MOI) of 104 resulted in a significant reduction of 8.8 log CFU/mL on S. aureus viable cells in a pasteurized milk study, compared to 4.3 CFU/cm2 in the cheddar cheese after 24 h exposure. The presence of phages allows reducing the intensity of physical treatments of the milk, such as high hydrostatic pressure, limiting its negative impact on the typicity and organoleptic quality of the product [101].
Other researchers have reported the beneficial effects of lytic phages on several pathogenic species in various food matrices, such as the inhibition of Enterobacter cloacae growth in pasteurized milk and yogurt by vB_EclM-EP1 and vB_EclM-EP2 phages [92]. Similarly, two multidrug-resistant strains of Vibrio parahaemolyticus and Vibrio cholerae isolated from water samples were effectively lysed by two phages, vB_VpM_SA3V and vB_VcM_SA3V, belonging to the former Myoviridae family [102]. Next, Choi et al. demonstrated the inhibitory properties of a polycaprolactone film prepared with T4 bacteriophage against Escherichia coli O157:H7 [86]. The efficacy of the bacteriophage AZO145A in inhibiting the formation of E. coli (STEC) O145:H25 biofilm was also reported, supporting its use to reduce the biofilm on stainless steel surfaces in the food industry [103]. Other applications of bacteriophages to reduce bacterial pathogens in various food matrices are listed in Table 2.
However, the protein nature of bacteriophages and their endolysins, coupled with their sensitivity to various external factors experienced during food processing, such as temperature, acidity and salinity, are at the root of phage instability in the food environment [104]. Among the solutions proposed is the search for and characterization of thermostable phages and endolysins, such as LysCPS2, active against Clostridium perfringens, with optimal conditions of pH 7.5–10 and a temperature of 25–65 °C, but also able to withstand 95 °C for 10 min [105]. Next, bacteriophage encapsulation was shown to be effective and a good alternative [106]. The stability of Lactococcus P008 phage protected by capsules of milk proteins provided improved protection at pH 2.0 compared to nonencapsulated bacteriophage [107]. In addition, combining phages with other antibacterial agents can increase their lytic power and overcome certain deficiencies [4,108].
Table 2. Examples of bacteriophages that could be used as biopreservative agents.
Table 2. Examples of bacteriophages that could be used as biopreservative agents.
BacteriophagesApplicationTarget MicroorganismReference
Phage BPECO19Chicken meatEscherichia coli O157:H7[109]
Phage A511Cooked meatListeria monocytogenes[110]
Phage Akh-2AquacultureAeromonas hydrophila[111]
Phages LSA2308 and LSA2366 (alone or as cocktail)Milk production chain Staphylococcus aureus[112]
Phage T156MilkSalmonella Typhimurium[113]
Phages SE-P3, P16, P37 and P47 (alone or as cocktail)Raw chicken meatSalmonella enteritidis[114]
Cocktail phages (C14 s, L1, V9 and LL15)Fruits and vegetablesEscherichia coli O157:H7[115]
Phage A511CheeseListeria monocytogenes[116]
PhageGuard ListexTM P100Fuet, cocked ham and fresh cheeseListeria innocua[117]

6. The Combination of Bacteriophage and Bacteriocin: A Tool against Foodborne Pathogens

The above-mentioned examples of applications of bacteriocins and/or bacteriophages in the food industry as biological and natural agents have been demonstrated alone or in combination in various studies recently reviewed by Rendueles et al. [4]. Note that the combination could also be extended to physical techniques. In fact, a three-way combination of a high-pressure treatment with bacteriophage P100 and a bacteriocinogenic strain of Pediococcus acidilactici was successfully used to inhibit L. monocytogenes in a fermented meat sausage preparation [94]. A synergistic effect with Pediocin PA-1/AcH in milk has also been reported [118]. Combining the same phage with Enterocin AS-48 inhibited the growth of L. monocytogenes in fish stored at 4 °C [119]. The importance of this synergy was confirmed in another experiment in which S. aureus strain KCTC 3881 was significantly inhibited by the combination of a bacteriocin produced by L. lactis CJNU 3001 and the SAP84 phage. This was compared with the effect of each treatment alone [53]. In addition, Heo et al. [120] reported that the combination of the bacteriocinogenic Streptococcus hyointestinalis B19 and a cocktail of two bacteriophages (P4 and A3) completely eradicated the strain C. perfringens KCTC 3269T [120]. Exploring and developing the potential of these natural antibacterial agents in the food sector certainly offers positive options to ensure that food products are highly protected and meet consumer expectations for naturally preserved foods.

7. Conclusions

The aim of this minireview was to support bacteriocins and bacteriophages as natural, effective means of food preservation. It is, therefore, timely and desirable to replace the chemical agents currently in use, which have been vociferously rejected by consumers around the world for their harmful effects on human health. However, regulations need to be harmonized to allow the gradual use of these natural substances, and further studies, particularly toxicological studies, are needed to prove their safety.

Funding

This research was funded by la CPER BiHauts Eco de France 2021/2027. BM acknowledges current funding by grant PID2020-119697RB-I00 funded by MCIN/AEI/10.13039/501100011033 and AYUD/2021/52120 (Program of Science, Technology and Innovation 2018–2022, Principado de Asturias, FICYT, FEDER, UE).

Conflicts of Interest

The authors declare do not have any conflict of interest.

References

  1. Brauge, T.; Faille, C.; Leleu, G.; Denis, C.; Hani, A.; Midelet, G. Treatment with disinfectants may induce an increase in viable but non-culturable populations of Listeria monocytogenes in biofilms formed in smoked salmon processing environments. Food Microbiol. 2020, 92, 103548. [Google Scholar] [CrossRef] [PubMed]
  2. Carrascosa, C.; Raheem, D.; Ramos, F.; Saraiva, A.; Raposo, A. Microbial Biofilms in the Food Industry—A Comprehensive Review. Int. J. Environ. Res. Public Health 2021, 18, 2014. [Google Scholar] [CrossRef] [PubMed]
  3. Wagh, R.V.; Priyadarshi, R.; Rhim, J.-W. Novel Bacteriophage-Based Food Packaging: An Innovative Food Safety Approach. Coatings 2023, 13, 609. [Google Scholar] [CrossRef]
  4. Rendueles, C.; Duarte, A.-C.; Escobedo, S.; Fernández, L.; Rodríguez, A.; García, P.; Martínez, B. Combined use of bacteriocins and bacteriophages as food biopreservatives. A review. Int. J. Food Microbiol. 2022, 368, 109611. [Google Scholar] [CrossRef] [PubMed]
  5. Muthuvelu, K.-S.; Ethiraj, B.; Pramnik, S.; Raj, N.-K.; Venkataraman, S.; Rajendran, D.-S.; Bharathi, P.; Palanisamy, E.; Narayanan, A.S.; Vaidyanathan, V.K.; et al. Biopreservative technologies of food: An alternative to chemical preservation and recent developments. Food Sci. Biotechnol. 2023, 32, 1337–1350. [Google Scholar] [CrossRef] [PubMed]
  6. Drider, D.; Rebuffat, S. Prokaryotic Antimicrobial Peptides: From Genes to Applications; Springer Science & Business Media: Berlin/Heidelberg, Germany, 2011. [Google Scholar]
  7. Whitehead, H.-R. A substance inhibiting bacterial growth, produced by certain strains of lactic streptococci. Biochem. J. 1933, 27, 1793–1800. [Google Scholar] [CrossRef] [PubMed]
  8. Jack, R.-W.; Tagg, J.R.; Ray, B. Bacteriocins of gram-positive bacteria. Microbiol. Mol. Biol. Rev. 1995, 59, 171–200. [Google Scholar] [CrossRef]
  9. Perez, R.-H.; Zendo, T.; Sonomoto, K. Multiple bacteriocin production in lactic acid bacteria. J. Biosci. Bioeng. 2022, 134, 277–287. [Google Scholar] [CrossRef]
  10. Gough, R.; O’Connor, P.-M.; Rea, M.-C.; Gómez-Sala, B.; Miao, S.; Hill, C.; Brodkorb, A. Simulated gastrointestinal digestion of nisin and interaction between nisin and bile. Lebensm.-Wiss. Technol. 2017, 86, 530–537. [Google Scholar] [CrossRef]
  11. Klaenhammer, T.-R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 1993, 12, 39–85. [Google Scholar] [CrossRef]
  12. Arnison, P.-G.; Bibb, M.-J.; Bierbaum, G.; Bowers, A.-A.; Bugni, T.-S.; Bulaj, G.; Camarero, J.A.; Campopiano, D.J.; Challis, G.L.; Clardy, J.; et al. Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature. Nat. Prod. Rep. 2012, 30, 108–160. [Google Scholar] [CrossRef] [PubMed]
  13. Cotter, P.-D.; Ross, R.-P.; Hill, C. Bacteriocins—A viable alternative to antibiotics? Nat. Rev. Microbiol. 2013, 11, 95–105. [Google Scholar] [CrossRef] [PubMed]
  14. Alvarez-Sieiro, P.; Montalbán-López, M.; Mu, D.; Kuipers, O.-P. Bacteriocins of lactic acid bacteria: Extending the family. Appl. Microbiol. Biotechnol. 2016, 100, 2939–2951. [Google Scholar] [CrossRef] [PubMed]
  15. Acedo, J.A.; Chiorean, S.; Vederas, J.C.; van Belkum, M.J. The expanding structural variety among bacteriocins from Gram-positive bacteria. FEMS Microbiol. Rev. 2018, 42, 805–828. [Google Scholar]
  16. Soltani, S.; Hammami, R.; Cotter, P.-D.; Rebuffat, S.; Said, L.-B.; Gaudrea, H.; Bédard, F.; Biron, E.; Drider, D.; Fliss, I. Bacteriocins as a new generation of antimicrobials: Toxicity aspects and regulations. FEMS Microbiol. Rev. 2021, 45, fuaa039. [Google Scholar] [CrossRef]
  17. Perez, R.-H.; Zendo, T.; Sonomoto, K. Novel bacteriocins from lactic acid bacteria (LAB): Various structures and applications. Microb. Cell Factories 2014, 13, S3. [Google Scholar] [CrossRef]
  18. Gálvez, A.; Abriouel, H.; López, R.-L.; Omar, N.-B. Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol. 2007, 120, 51–70. [Google Scholar]
  19. Stern, N.-J.; Svetoch, E.-A.; Eruslanov, B.-V.; Perelygin, V.-V.; Mitsevich, E.-V.; Mitsevich, I.-P.; Pokhilenko, V.D.; Levchuk, V.P.; Svetoch, O.E.; Seal, B.S. Isolation of a Lactobacillus salivarius Strain and Purification of Its Bacteriocin, Which Is Inhibitory to Campylobacter jejuni in the Chicken Gastrointestinal System. Antimicrob. Agents Chemother. 2006, 50, 3111–3116. [Google Scholar] [CrossRef]
  20. Line, J.E.; Svetoch, E.A.; Eruslanov, B.V.; Perelygin, V.V.; Mitsevich, E.V.; Mitsevich, I.P.; Levchuk, V.P.; Svetoch, O.E.; Seal, B.S.; Siragusa, G.R.; et al. Isolation and Purification of Enterocin E-760 with Broad Antimicrobial Activity against Gram-Positive and Gram-Negative Bacteria. Antimicro. Agents Chemother. 2008, 52, 1094–1100. [Google Scholar] [CrossRef]
  21. Messaoudi, S.; Madi, A.; Prévost, H.; Feuilloley, M.; Manai, M.; Dousset, X.; Connil, N. In Vitro evaluation of the probiotic potential of Lactobacillus salivarius SMXD51. Anaerobe 2012, 18, 584–589. [Google Scholar] [CrossRef]
  22. Song, D.-F.; Zhu, M.-Y.; Gu, Q. Purification and Characterization of Plantaricin ZJ5, a New Bacteriocin Produced by Lactobacillus plantarum ZJ5. PLoS ONE 2020, 9, e105549. [Google Scholar] [CrossRef] [PubMed]
  23. Madi-Moussa, D.; Deracinois, B.; Teiar, R.; Li, Y.; Mihasan, M.; Flahaut, C.; Rebuffat, S.; Coucheney, F.; Drider, D. Structure of Lacticaseicin 30 and Its Engineered Variants Revealed an Interplay between the N-Terminal and C-Terminal Regions in the Activity against Gram-Negative Bacteria. Pharmaceutics 2022, 14, 1921. [Google Scholar] [CrossRef] [PubMed]
  24. Prudêncio, C.-V.; dos Santos, M.-T.; Vanetti, M.-C.-D. Strategies for the use of bacteriocins in Gram-negative bacteria: Relevance in food microbiology. J. Food Sci. Technol. 2015, 52, 5408–5417. [Google Scholar] [CrossRef] [PubMed]
  25. Pérez-Ramos, A.; Madi-Moussa, D.; Coucheney, F.; Drider, D. Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins. Microorganisms 2021, 9, 2107. [Google Scholar] [CrossRef] [PubMed]
  26. Lahiri, D.; Nag, M.; Dutta, B.; Sarkar, T.; Pati, S.; Basu, D.; Kari, Z.A.; Wei, L.S.; Smaoui, S.; Goh, K.W.; et al. Bacteriocin: A natural approach for food safety and food security. Front. Bioeng. Biotechnol. 2022, 10, 1005918. [Google Scholar] [CrossRef] [PubMed]
  27. Camargo, A.-C.; Todorov, S.-D.; Chihib, N.-E.; Drider, D.; Nero, L.-A. Lactic Acid Bacteria (LAB) and Their Bacteriocins as Alternative Biotechnological Tools to Control Listeria monocytogenes Biofilms in Food Processing Facilities. Mol. Biotechnol. 2018, 60, 712–726. [Google Scholar] [CrossRef]
  28. Kirtonia, K.; Salauddin, M.; Bharadwaj, K.-K.; Pati, S.; Dey, A.; Shariati, M.-A.; Tilak, V.K.; Kuznetsova, E.; Sarkar, T. Bacteriocin: A new strategic antibiofilm agent in food industries. Biocat. Agric. Biotechnol. 2021, 36, 102141. [Google Scholar] [CrossRef]
  29. Castellano, P.; Pérez-Ibarreche, M.; Blanco-Massani, M.; Fontana, C.; Vignolo, G.-M. Strategies for Pathogen Biocontrol Using Lactic Acid Bacteria and Their Metabolites: A Focus on Meat Ecosystems and Industrial Environments. Microorganisms 2017, 5, 38. [Google Scholar] [CrossRef]
  30. Kumariya, R.; Garsa, A.-K.; Rajput, Y.-S.; Sood, S.-K.; Akhtar, N.; Patel, S. Bacteriocins: Classification, synthesis, mechanism of action and resistance development in food spoilage causing bacteria. Microb. Pathog. 2019, 128, 171–177. [Google Scholar] [CrossRef]
  31. Bhattacharya, D.; Nanda, P.-K.; Pateiro, M.; Lorenzo, J.-M.; Dhar, P.; Das, A.-K. Lactic Acid Bacteria and Bacteriocins: Novel Biotechnological Approach for Biopreservation of Meat and Meat Products. Microorganisms 2022, 10, 2058. [Google Scholar] [CrossRef]
  32. Borges, F.; Briandet, R.; Callon, C.; Champomier-Vergès, M.-C.; Christieans, S.; Chuzeville, S.; Denis, C.; Desmasures, N.; Desmonts, M.-H.; Feurer, C.; et al. Contribution of omics to biopreservation: Toward food microbiome engineering. Front. Microbiol. 2022, 13, 951182. [Google Scholar] [CrossRef] [PubMed]
  33. Todorov, S.-D.; Popov, I.; Weeks, R.; Chikindas, M.-L. Use of Bacteriocins and Bacteriocinogenic Beneficial Organisms in Food Products: Benefits, Challenges, Concerns. Foods 2022, 11, 3145. [Google Scholar] [CrossRef] [PubMed]
  34. Speranza, B.; Corbo, M.-R. Chapter 11—The Impact of Biofilms on Food Spoilage. In The Microbiological Quality of Food; Bevilacqua, A., Corbo, M.R., Sinigaglia, M., Eds.; Woodhead Publishing: Cambridge, UK, 2017; pp. 259–282. [Google Scholar]
  35. Speranza, B.; Liso, A.; Russo, V.; Corbo, M.-R. Evaluation of the Potential of Biofilm Formation of Bifidobacterium longum subsp. infantis and Lactobacillus reuteri as Competitive Biocontrol Agents Against Pathogenic and Food Spoilage Bacteria. Microorganisms 2020, 8, 177. [Google Scholar] [CrossRef] [PubMed]
  36. Pang, X.; Song, X.; Chen, M.; Tian, S.; Lu, Z.; Sun, J.; Li, X.; Lu, Y.; Yuk, H. Combating biofilms of foodborne pathogens with bacteriocins by lactic acid bacteria in the food industry. Compr. Rev. Food Sci. Food Saf. 2022, 21, 1657–1676. [Google Scholar] [CrossRef]
  37. Richard, C.; Brillet, A.; Pilet, M.-F.; Prévost, H.; Drider, D. Evidence on inhibition of Listeria monocytogenes by divercin V41 action. Lett. Appl. Microbiol. 2003, 36, 288–292. [Google Scholar] [CrossRef] [PubMed]
  38. Yoon, S.-H.; Kim, G.-B. Inhibition of Listeria monocytogenes in Fresh Cheese Using a Bacteriocin-Producing Lactococcus lactis CAU2013 Strain. Food Sci. Anim. Resour. 2022, 42, 1009–1019. [Google Scholar] [CrossRef] [PubMed]
  39. Zou, J.; Jiang, H.; Cheng, H.; Fang, J.; Huang, G. Strategies for screening, purification and characterization of bacteriocins. Int. J. Biol. Macromol. 2018, 117, 781–789. [Google Scholar] [CrossRef]
  40. Lahiri, D.; Chakraborti, S.; Jasu, A.; Nag, M.; Dutta, B.; Dash, S.; Ray, R.R. Production and purification of bacteriocin from Leuconostoc lactis SM 2 strain. Biocat. Agric. Biotechnol. 2020, 30, 101845. [Google Scholar] [CrossRef]
  41. O’Connor, P.-M.; Kuniyoshi, T.-M.; Oliveira, R.-P.; Hill, C.; Ross, R.-P.; Cotter, P.-D. Antimicrobials for food and feed; a bacteriocin perspective. Curr. Opin. Biotechnol. 2020, 61, 160–167. [Google Scholar] [CrossRef]
  42. Shafique, B.; Ranjha, M.-M.-A.-N.; Murtaza, M.-A.; Walayat, N.; Nawaz, A.; Khalid, W.; Mahmood, S.; Nadeem, M.; Manzoor, M.F.; Ameer, K.; et al. Recent Trends and Applications of Nanoencapsulated Bacteriocins against Microbes in Food Quality and Safety. Microorganisms 2023, 11, 85. [Google Scholar] [CrossRef]
  43. Realini, C.-E.; Marcos, B. Active and intelligent packaging systems for a modern society. Meat Sci. 2014, 98, 404–419. [Google Scholar] [CrossRef] [PubMed]
  44. Daba, G.M.; Elkhateeb, W.A. Bacteriocins of lactic acid bacteria as biotechnological tools in food and pharmaceuticals: Current applications and future prospects. Biocatal. Agric. Biotechnol. 2020, 28, 101750. [Google Scholar] [CrossRef]
  45. Mokoena, M.-P. Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review. Molecules 2017, 22, 1255. [Google Scholar] [CrossRef] [PubMed]
  46. Silva, C.C.G.; Silva, S.P.M.; Ribeiro, S.C. Application of Bacteriocins and Protective Cultures in Dairy Food Preservation. Front. Microbiol. 2018, 9, 594. [Google Scholar] [CrossRef] [PubMed]
  47. Hussien, H.; Abd-Rabou, H.-S.; Saad, M.-A. The impact of incorporating Lactobacillus acidophilus bacteriocin with inulin and FOS on yogurt quality. Sci. Rep. 2022, 12, 13401. [Google Scholar] [CrossRef] [PubMed]
  48. Bukvicki, D.; D’Alessandro, M.; Rossi, S.; Siroli, L.; Gottardi, D.; Braschi, G.; Patrignani, F.; Lanciotti, R. Essential Oils and Their Combination with Lactic Acid Bacteria and Bacteriocins to Improve the Safety and Shelf Life of Foods: A Review. Foods 2023, 12, 3288. [Google Scholar] [CrossRef] [PubMed]
  49. Wu, M.; Dong, Q.; Song, X.; Xu, L.; Xia, X.; Aslam, M.-Z.; Ma, Y.; Qin, X.; Wang, X.; Liu, Y.; et al. Effective combination of nisin and sesamol against Listeria monocytogenes. LWT—Food Sci. Technol. 2023, 176, 114546. [Google Scholar] [CrossRef]
  50. Austrich-Comas, A.; Serra-Castelló, C.; Jofré, A.; Gou, P.; Bover-Cid, S. Control of Listeria monocytogenes in chicken dry-fermented sausages with bioprotective starter culture and high-pressure processing. Front. Microbiol. 2023, 13, 983265. [Google Scholar] [CrossRef]
  51. da Costa, R.-J.; Voloski, F.-L.-S.; Mondadori, R.-G.; Duval, E.-H.; Fiorentini, Â.-M. Preservation of Meat Products with Bacteriocins Produced by Lactic Acid Bacteria Isolated from Meat. J. Food Qual. 2019, 2019, e4726510. [Google Scholar] [CrossRef]
  52. Leverentz, B.; Conway, W.S.; Camp, M.J.; Janisiewicz, W.J.; Abuladze, T.; Yang, M.; Saftner, R.; Sulakvelidze, A. Biocontrol of Listeria monocytogenes on Fresh-Cut Produce by Treatment with Lytic Bacteriophages and a Bacteriocin. Appl. Environ. Microbiol. 2003, 69, 4519–4526. [Google Scholar] [CrossRef]
  53. Kim, S.-G.; Lee, Y.-D.; Park, J.-H.; Moon, G.-S. Synergistic Inhibition by Bacteriocin and Bacteriophage against Staphylococcus aureus. Food Sci. Anim. Resour. 2019, 39, 1015–1020. [Google Scholar] [CrossRef] [PubMed]
  54. Goff, J.-H.; Bhunia, A.-K.; Johnson, M.-G. Complete Inhibition of Low Levels of Listeria monocytogenes on Refrigerated Chicken Meat with Pediocin AcH Bound to Heat-Killed Pediococcus acidilactici Cells. J. Food Prot. 1996, 59, 1187–1192. [Google Scholar] [CrossRef]
  55. Katla, T.; Møretrø, T.; Sveen, I.; Aasen, I.M.; Axelsson, L.; Rørvik, L.M.; Naterstad, K. Inhibition of Listeria Monocytogenes in Chicken Cold Cuts by Addition of Sakacin P and Sakacin P-producing Lactobacillus Sakei. J. Appl. Microbiol. 2002, 93, 191–196. [Google Scholar] [CrossRef] [PubMed]
  56. Marcos, B.; Aymerich, T.; Monfort, J.-M.; Garriga, M. High-pressure processing and antimicrobial biodegradable packaging to control Listeria monocytogenes during storage of cooked ham. Food Microbiol. 2008, 25, 177–182. [Google Scholar] [CrossRef] [PubMed]
  57. Basanta, A.; Sánchez, J.; Gómez-Sala, B.; Herranz, C.; Hernández, P.-E.; Cintas, L.-M. Antimicrobial activity of Enterococcus faecium L50, a strain producing enterocins L50 (L50A and L50B), P and Q, against beer-spoilage lactic acid bacteria in broth, wort (hopped and unhopped), and alcoholic and non-alcoholic lager beers. Int. J. Food Microbiol. 2008, 125, 293–307. [Google Scholar] [CrossRef] [PubMed]
  58. Chakchouk-Mtibaa, A.; Smaoui, S.; Ktari, N.; Sellem, I.; Najah, S.; Karray-Rebai, I.; Mellouli, L. Biopreservative Efficacy of Bacteriocin BacFL31 in Raw Ground Turkey Meat in terms of Microbiological, Physicochemical, and Sensory Qualities. Biocontrol Sci. 2017, 22, 67–77. [Google Scholar] [CrossRef] [PubMed]
  59. Mills, S.; Griffin, C.; O’Connor, P.-M.; Serrano, L.-M.; Meijer, W.C.; Hill, C.; Ross, R.P. A Multibacteriocin Cheese Starter System, Comprising Nisin and Lacticin 3147 in Lactococcus lactis, in Combination with Plantaricin from Lactobacillus plantarum. Appl. Envrion. Microbiol. 2017, 83, e00799-17. [Google Scholar] [CrossRef] [PubMed]
  60. Pei, J.; Yue, T.; Yuan, Y.; Dai, L. Activity of paracin C from lactic acid bacteria against Alicyclobacillus in apple juice: Application of a novelty bacteriocin. J. Food Saf. 2017, 37, e12350. [Google Scholar] [CrossRef]
  61. Xie, Y.; Zhang, M.; Gao, X.; Shao, Y.; Liu, H.; Jin, J.; Yang, W.; Zhang, H. Development and antimicrobial application of plantaricin BM-1 incorporating a PVDC film on fresh pork meat during cold storage. J. Appl. Microbiol. 2018, 125, 1108–1116. [Google Scholar] [CrossRef]
  62. Lu, Y.; Aizhan, R.; Yan, H.; Li, X.; Wang, X.; Yi, Y.; Shan, Y.; Liu, B.; Zhou, Y.; Lü, X. Characterization, modes of action, and application of a novel broad-spectrum bacteriocin BM1300 produced by Lactobacillus crustorum MN047. Braz. J. Microbiol. 2020, 51, 2033–2048. [Google Scholar] [CrossRef]
  63. Lazzeri, A.-M.; Mangia, N.-P.; Mura, M.-E.; Floris, I.; Satta, A.; Ruiu, L. Potential of novel food-borne Lactobacillus isolates against the honeybee pathogen Paenibacillus larvae. Biocontrol. Sci. Technol. 2020, 30, 897–908. [Google Scholar] [CrossRef]
  64. Fotso Techeu, U.-D.; Kaktcham, P.-M.; Momo, H.-K.; Foko Kouam, E.-M.; Tchamani-Piame, L.; Ngouenam, R.-J.; Zambou Ngoufack, F. Isolation, Characterization, and Effect on Biofilm Formation of Bacteriocin Produced by Lactococcus lactis F01 Isolated from Cyprinus carpio and Application for Biopreservation of Fish Sausage. BioMed Res. Int. 2022, 2022, e8437926. [Google Scholar] [CrossRef] [PubMed]
  65. Petkova, M.; Gotcheva, V.; Dimova, M.; Bartkiene, E.; Rocha, J.-M.; Angelov, A. Screening of Lactiplantibacillus plantarum Strains from Sourdoughs for Biosuppression of Pseudomonas syringae pv. syringae and Botrytis cinerea in Table Grapes. Microorganisms 2022, 10, 2094. [Google Scholar] [CrossRef] [PubMed]
  66. Shan, C.; Wu, H.; Zhu, Y.; Zhou, J.; Yan, W.; Jianhao, Z.; Liu, X. Preservative effects of a novel bacteriocin from Lactobacillus panis C-M2 combined with dielectric barrier discharged cold plasma (DBD-CP) on acquatic foods. Food Sci. Technol. Int. 2023, 29, 406–416. [Google Scholar] [CrossRef] [PubMed]
  67. Silva, S.P.M.; Teixeira, J.A.; Silva, C.C.G. Application of enterocin-whey films to reduce Listeria monocytogenes contamination on ripened cheese. Food Microbiol. 2023, 109, 104134. [Google Scholar] [CrossRef]
  68. d’Herelle, F. An invisible microbe that is antagonistic to the dysentery bacillus. CR Acad. Sci. 1917, 165, 373–375. [Google Scholar]
  69. Sulakvelidze, A.; Alavidze, Z.; Morris, J.-G. Bacteriophage Therapy. Antimicrob. Agents Chemother. 2001, 45, 649–659. [Google Scholar] [CrossRef]
  70. Atterbury, R.-J. Bacteriophage biocontrol in animals and meat products. Microb. Biotechnol. 2009, 2, 601–612. [Google Scholar] [CrossRef]
  71. Fernández, L.; Gutiérrez, D.; Rodríguez, A.; García, P. Application of Bacteriophages in the Agro-Food Sector: A Long Way Toward Approval. Front. Cell Infect. Microbiol. 2018, 8, 296. [Google Scholar] [CrossRef]
  72. O’Sullivan, L.; Bolton, D.; McAuliffe, O.; Coffey, A. Bacteriophages in Food Applications: From Foe to Friend. Annu. Rev. Food Sci. Technol. 2019, 10, 151–172. [Google Scholar] [CrossRef]
  73. Gordillo-Altamirano, F.-L.; Barr, J.-J. Phage Therapy in the Postantibiotic Era. Clin. Microbiol. Rev. 2019, 32, e00066-18. [Google Scholar] [CrossRef] [PubMed]
  74. Hendrix, R.-W.; Smith, M.-C.-M.; Burns, R.-N.; Ford, M.-E.; Hatfull, G.-F. Evolutionary relationships among diverse bacteriophages and prophages: All the world’s a phage. Proc. Natl. Acad. Sci. USA 1999, 96, 2192–2197. [Google Scholar] [CrossRef]
  75. Ackermann, H.-W. Bacteriophage taxonomy. Microbiology 2011, 32, 90–94. [Google Scholar] [CrossRef]
  76. Turner, D.; Kropinski, A.-M.; Adriaenssens, E.-M. A Roadmap for Genome-Based Phage Taxonomy. Viruses 2021, 13, 506. [Google Scholar] [CrossRef] [PubMed]
  77. Mills, S.; Ross, R.-P.; Hill, C. Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology. FEMS Microbiol. Rev. 2017, 41 (Suppl. 1), S129–S153. [Google Scholar] [CrossRef]
  78. AL-Ishaq, R.-K.; Skariah, S.; Büsselberg, D. Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens. Viruses 2021, 13, 51. [Google Scholar] [CrossRef]
  79. Wernicki, A.; Nowaczek, A.; Urban-Chmiel, R. Bacteriophage therapy to combat bacterial infections in poultry. Virol. J. 2017, 14, 179. [Google Scholar] [CrossRef]
  80. Fister, S.; Robben, C.; Witte, A.-K.; Schoder, D.; Wagner, M.; Rossmanith, P. Influence of Environmental Factors on Phage–Bacteria Interaction and on the Efficacy and Infectivity of Phage P100. Front. Microbiol. 2016, 7, 1152. [Google Scholar] [CrossRef]
  81. Nabergoj, D.; Modic, P.; Podgornik, A. Effect of bacterial growth rate on bacteriophage population growth rate. MicrobiologyOpen 2018, 7, e00558. [Google Scholar] [CrossRef]
  82. Fernández, L.; Escobedo, S.; Gutiérrez, D.; Portilla, S.; Martínez, B.; García, P.; Rodríguez, A. Bacteriophages in the Dairy Environment: From Enemies to Allies. Antibiotics 2017, 6, 27. [Google Scholar] [CrossRef]
  83. Kazi, M.; Annapure, U.-S. Bacteriophage biocontrol of foodborne pathogens. J. Food Sci. Technol. 2016, 53, 1355–1362. [Google Scholar] [CrossRef] [PubMed]
  84. Moye, Z.-D.; Woolston, J.; Sulakvelidze, A. Bacteriophage Applications for Food Production and Processing. Viruses 2018, 10, 205. [Google Scholar] [CrossRef] [PubMed]
  85. Hyla, K.; Dusza, I.; Skaradzińska, A. Recent Advances in the Application of Bacteriophages against Common Foodborne Pathogens. Antibiotics 2022, 11, 536. [Google Scholar] [CrossRef] [PubMed]
  86. Choi, I.; Yoo, D.-S.; Chang, Y.; Kim, S.-Y.; Han, J. Polycaprolactone film functionalized with bacteriophage T4 promotes antibacterial activity of food packaging toward Escherichia coli. Food Chem. 2021, 346, 128883. [Google Scholar] [CrossRef] [PubMed]
  87. Kering, K.-K.; Kibii, B.-J.; Wei, H. Biocontrol of phytobacteria with bacteriophage cocktails. Pest. Manag. Sci. 2019, 75, 1775–1781. [Google Scholar] [CrossRef]
  88. Vu, N.-T.; Oh, C.-S. Bacteriophage Usage for Bacterial Disease Management and Diagnosis in Plants. Plant Pathol. J. 2020, 36, 204–217. [Google Scholar] [CrossRef]
  89. Jassim, S.-A.-A.; Limoges, R.-G.; El-Cheikh, H. Bacteriophage biocontrol in wastewater treatment. World J. Microbiol. Biotechnol. 2016, 32, 70. [Google Scholar] [CrossRef]
  90. O’Sullivan, L.; Bolton, D.; McAuliffe, O.; Coffey, A. The use of bacteriophages to control and detect pathogens in the dairy industry. Int. J. Dairy Technol. 2020, 73, 1–11. [Google Scholar] [CrossRef]
  91. Falardeau, J.; Trmčić, A.; Wang, S. The occurrence, growth, and biocontrol of Listeria monocytogenes in fresh and surface-ripened soft and semisoft cheeses. Compr. Rev. Food Sci. Food Saf. 2021, 20, 4019–4048. [Google Scholar] [CrossRef]
  92. Nasr-Eldin, M.A.; Gamal, E.; Hazz, A.M.; Abo-Elmaaty, S.A. Isolation, characterization, and application of lytic bacteriophages for controlling Enterobacter cloacae complex (ECC) in pasteurized milk and yogurt. Folia Microbiol. 2023, 68, 911–924. [Google Scholar] [CrossRef]
  93. Axelsson, L.; Bjerke, G.A.; McLeod, A.; Berget, I.; Holck, A.L. Growth Behavior of Listeria monocytogenes in a Traditional Norwegian Fermented Fish Product (Rakfisk), and Its Inhibition through Bacteriophage Addition. Foods 2020, 9, 119. [Google Scholar] [CrossRef] [PubMed]
  94. Komora, N.; Maciel, C.; Amaral, R.A.; Fernandes, R.; Castro, S.M.; Saraiva, J.A.; Teixeira, P. Innovative hurdle system towards Listeria monocytogenes inactivation in a fermented meat sausage model—High pressure processing assisted by bacteriophage P100 and bacteriocinogenic Pediococcus acidilactici. Food Res. Int. 2021, 148, 110628. [Google Scholar] [CrossRef] [PubMed]
  95. Parsons, C.; Brown, P.; Kathariou, S. Use of Bacteriophage Amended with CRISPR-Cas Systems to Combat Antimicrobial Resistance in the Bacterial Foodborne Pathogen Listeria monocytogenes. Antibiotics 2021, 10, 308. [Google Scholar] [CrossRef] [PubMed]
  96. Jakobsen, R.R.; Trinh, J.T.; Bomholtz, L.; Brok-Lauridsen, S.K.; Sulakvelidze, A.; Nielsen, D.S. Bacteriophage Cocktail Significantly Reduces Listeria monocytogenes without Deleterious Impact on the Commensal Gut Microbiota under Simulated Gastrointestinal Conditions. Viruses 2022, 14, 190. [Google Scholar] [CrossRef] [PubMed]
  97. Strydom, A.; Witthuhn, C.R. Listeria monocytogenes: A Target for Bacteriophage Biocontrol. Compr. Rev. Food Sci. Food Saf. 2015, 14, 694–704. [Google Scholar] [CrossRef]
  98. Rodríguez-Melcón, C.; Capita, R.; García-Fernández, C.; Alonso-Calleja, C. Effects of Bacteriophage P100 at Different Concentrations on the Structural Parameters of Listeria monocytogenes Biofilms. J. Food Prot. 2018, 81, 2040–2044. [Google Scholar] [CrossRef]
  99. Yan, J.; Yang, R.; Yu, S.; Zhao, W. The strategy of biopreservation of meat product against MRSA using lytic domain of lysin from Staphylococcus aureus bacteriophage. Food Biosci. 2021, 41, 100967. [Google Scholar] [CrossRef]
  100. Kwak, H.; Kim, J.; Ryu, S.; Bai, J. Characterization of KMSP1, a newly isolated virulent bacteriophage infecting Staphylococcus aureus, and its application to dairy products. Int. J. Food Microbiol. 2023, 390, 110119. [Google Scholar] [CrossRef]
  101. Tabla, R.; Martínez, B.; Rebollo, J.E.; González, J.; Ramírez, M.R.; Roa, I.; Rodríguez, A.; García, P. Bacteriophage performance against Staphylococcus aureus in milk is improved by high hydrostatic pressure treatments. Int. J. Food Microbiol. 2012, 156, 209–213. [Google Scholar] [CrossRef]
  102. Maje, M.D.; Kaptchouang Tchatchouang, C.D.; Manganyi, M.C.; Fri, J.; Ateba, C.N. Characterisation of Vibrio Species from Surface and Drinking Water Sources and Assessment of Biocontrol Potentials of Their Bacteriophages. Int. J. Microbiol. 2020, 2020, e8863370. [Google Scholar] [CrossRef]
  103. Wang, C.; Hang, H.; Zhou, S.; Niu, Y.D.; Du, H.; Stanford, K.; McAllister, T.A. Bacteriophage biocontrol of Shiga toxigenic Escherichia coli (STEC) O145 biofilms on stainless steel reduces the contamination of beef. Food Microbiol. 2020, 92, 103572. [Google Scholar] [CrossRef] [PubMed]
  104. Lee, C.; Kim, H.; Ryu, S. Bacteriophage and endolysin engineering for biocontrol of food pathogens/pathogens in the food: Recent advances and future trends. Crit. Rev. Food Sci. Nutr. 2022, 63, 8919–8938. [Google Scholar] [CrossRef] [PubMed]
  105. Ha, E.; Son, B.; Ryu, S. Clostridium perfringens Virulent Bacteriophage CPS2 and Its Thermostable Endolysin LysCPS2. Viruses 2018, 10, 251. [Google Scholar] [CrossRef] [PubMed]
  106. Połaska, M.; Sokołowska, B. Bacteriophages—A new hope or a huge problem in the food industry. AIMS Microbiol. 2019, 5, 324–346. [Google Scholar] [CrossRef]
  107. Samtlebe, M.; Ergin, F.; Wagner, N.; Neve, H.; Küçükçetin, A.; Franz, C.M.A.P.; Heller, K.J.; Hinrichs, J.; Atamer, Z. Carrier systems for bacteriophages to supplement food systems: Encapsulation and controlled release to modulate the human gut microbiota. LWT—Food Sci. Technol. 2016, 68, 334–340. [Google Scholar] [CrossRef]
  108. Endersen, L.; Coffey, A. The use of bacteriophages for food safety. Curr. Opin. Food Sci. 2020, 36, 1–8. [Google Scholar] [CrossRef]
  109. Seo, J.; Seo, D.J.; Oh, H.; Jeon, S.B.; Oh, M.H.; Choi, C. Inhibiting the Growth of Escherichia coli O157:H7 in Beef, Pork, and Chicken Meat using a Bacteriophage. Korean J. Food Sci. Anim. Resour. 2016, 36, 186–193. [Google Scholar] [CrossRef]
  110. Ahmadi, H.; Barbut, S.; Lim, L.T.; Balamurugan, S. Examination of the Use of Bacteriophage as an Additive and Determining Its Best Application Method to Control Listeria monocytogenes in a Cooked-Meat Model System. Front. Microbiol. 2020, 11, 779. [Google Scholar] [CrossRef]
  111. Akmal, M.; Rahimi-Midani, A.; Hafeez-ur-Rehman, M.; Hussain, A.; Choi, T.J. Isolation, Characterization, and Application of a Bacteriophage Infecting the Fish Pathogen Aeromonas hydrophila. Pathogens 2020, 9, 215. [Google Scholar] [CrossRef]
  112. Ma, F.; Ning, Y.; Wan, Q.; Zou, L.; Liu, Y.; Chen, S.; Li, J.; Zeng, Z.; Yang, Y.; Chen, H.; et al. Bacteriophages LSA2308 and LSA2366 infecting drug-resistant Staphylococcus aureus: Isolation, characterization and potential application for milk safety. LWT—Food Sci. Technol. 2021, 152, 112298. [Google Scholar] [CrossRef]
  113. Li, J.; Li, Y.; Ding, Y.; Huang, C.; Zhang, Y.; Wang, J.; Wang, X. Characterization of a novel Siphoviridae Salmonella bacteriophage T156 and its microencapsulation application in food matrix. Food Res. Int. 2021, 140, 110004. [Google Scholar] [CrossRef] [PubMed]
  114. Aydin Demirarslan, Ö.; Alasalvar, H.; Yildirim, Z. Biocontrol of Salmonella Enteritidis on chicken meat and skin using lytic SE-P3, P16, P37, and P47 bacteriophages. LWT—Food Sci. Technol. 2021, 137, 110469. [Google Scholar] [CrossRef]
  115. Vengarai Jagannathan, B.; Kitchens, S.; Priyesh Vijayakumar, P.; Price, S.; Morgan, M. Efficacy of Bacteriophage Cocktail to Control, E. coli O157:H7 Contamination on Baby Spinach Leaves in the Presence or Absence of Organic Load. Microorganisms 2021, 9, 544. [Google Scholar] [CrossRef] [PubMed]
  116. García-Anaya, M.C.; Sepulveda, D.R.; Rios-Velasco, C.; Acosta-Muñiz, C.H. Incorporation of A511 bacteriophage in a whey protein isolate-based edible coating for the control of Listeria monocytogenes in Cheese. Food Packag. Shelf Life 2023, 37, 101095. [Google Scholar] [CrossRef]
  117. Colás-Medà, P.; Viñas, I.; Alegre, I. Evaluation of Commercial Anti-Listerial Products for Improvement of Food Safety in Ready-to-Eat Meat and Dairy Products. Antibiotics 2023, 12, 414. [Google Scholar] [CrossRef] [PubMed]
  118. Komora, N.; Maciel, C.; Pinto, C.A.; Ferreira, V.; Brandão, T.R.S.; Saraiva, J.M.A.; Castro, S.M.; Teixeira, P. Non-thermal approach to Listeria monocytogenes inactivation in milk: The combined effect of high pressure, pediocin PA-1 and bacteriophage P100. Food Microbiol. 2020, 86, 103315. [Google Scholar] [CrossRef]
  119. Baños, A.; García-López, J.D.; Núñez, C.; Martínez-Bueno, M.; Maqueda, M.; Valdivia, E. Biocontrol of Listeria monocytogenes in fish by enterocin AS-48 and Listeria lytic bacteriophage P100. LWT—Food Sci. Technol. 2016, 66, 672–677. [Google Scholar] [CrossRef]
  120. Heo, S.; Kim, M.G.; Kwon, M.; Lee, H.S.; Kim, G.B. Inhibition of Clostridium perfringens using Bacteriophages and Bacteriocin Producing Strains. Korean J. Food Sci. Anim. Resour. 2018, 38, 88–98. [Google Scholar]
Figure 1. Biopreservation of food by the synergistic effect of an association between bacteriophages and a bacteriocin produced by a bacteriocinogenic bacterium, which can also play the role of starter (1) consortium of phages, (2) adsorption of bacteriophages to foodborne pathogenic bacteria by specific binding to cell receptors, (3) absence of binding between the bacteriophages and the bacteriocin-producing bacteria, (4) inhibition of pathogens by the phage lytic cycle, which ends with cell lysis involving holins and endolysins, (5) plus the antagonistic effect of bacteriocin on the integrity of the cytoplasmic membrane and peptidoglycan. Figure created with BioRender.com.
Figure 1. Biopreservation of food by the synergistic effect of an association between bacteriophages and a bacteriocin produced by a bacteriocinogenic bacterium, which can also play the role of starter (1) consortium of phages, (2) adsorption of bacteriophages to foodborne pathogenic bacteria by specific binding to cell receptors, (3) absence of binding between the bacteriophages and the bacteriocin-producing bacteria, (4) inhibition of pathogens by the phage lytic cycle, which ends with cell lysis involving holins and endolysins, (5) plus the antagonistic effect of bacteriocin on the integrity of the cytoplasmic membrane and peptidoglycan. Figure created with BioRender.com.
Encyclopedia 04 00007 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Barache, N.; Belguesmia, Y.; Martinez, B.; Seal, B.S.; Drider, D. Bacteriocins and Bacteriophages as Dual Biological Players for Food Safety Applications. Encyclopedia 2024, 4, 79-90. https://doi.org/10.3390/encyclopedia4010007

AMA Style

Barache N, Belguesmia Y, Martinez B, Seal BS, Drider D. Bacteriocins and Bacteriophages as Dual Biological Players for Food Safety Applications. Encyclopedia. 2024; 4(1):79-90. https://doi.org/10.3390/encyclopedia4010007

Chicago/Turabian Style

Barache, Nacim, Yanath Belguesmia, Beatriz Martinez, Bruce S. Seal, and Djamel Drider. 2024. "Bacteriocins and Bacteriophages as Dual Biological Players for Food Safety Applications" Encyclopedia 4, no. 1: 79-90. https://doi.org/10.3390/encyclopedia4010007

APA Style

Barache, N., Belguesmia, Y., Martinez, B., Seal, B. S., & Drider, D. (2024). Bacteriocins and Bacteriophages as Dual Biological Players for Food Safety Applications. Encyclopedia, 4(1), 79-90. https://doi.org/10.3390/encyclopedia4010007

Article Metrics

Back to TopTop